Aldagen, a venture funded startup with a set of technologies to identify and isolate stem and progenitor cells, has recently announced a partnership with IMT to develop a microfluidic device for clinical cell sorting. We recently spoke with the President and COO of the company, Ed Field, and discussed Aldagen’s business model, marketing and regulatory approval efforts as well as its ongoing round of financing.